SHANGHAI, Nov. 15, 2022 /PRNewswire/ -- Reistone Biopharma (Reistone), a leading biotech company focused on development of innovative medicines for immune and inflammation diseases

The market of autoimmune diseases medication is vast both in China and overseas and presents great opportunities. However, the number of Chinese players specializing in autoimmune diseases is limited.

- SHR0302 ointment, a topical, selective JAK1 inhibitor, met key primary and secondary endpoints, demonstrating sig...